WAP
ARNA

Wealthcare Advisory Partners’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Wealthcare Advisory Partners’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-130
Closed -$9K – 2069
2021
Q1 		$9K Buy
+130
New +$10K ﹤0.01% 1507
2020
Q2 		– Sell
-110
Closed -$5K – 1485
2020
Q1 		$5K Buy
+110
New +$5.04K ﹤0.01% 1132

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wealthcare Advisory Partners's ARNA Position: Q2 2021 in Review

Wealthcare Advisory Partners sold out of Arena Pharmaceuticals Inc (ARNA) in Q2 2021, closing a stake of 130 shares — an estimated $9K sold.

Wealthcare Advisory Partners first reported a position in ARNA in Q1 2020 and held it in 2 quarters. The position peaked at $9K in Q1 2021. 237 funds tracked by Wall St. Rank hold ARNA as of Q2 2021.

  • Wealthcare Advisory Partners reported no remaining Arena Pharmaceuticals Inc position as of Q2 2021 after selling out during the quarter.
  • Wealthcare Advisory Partners sold 130 Arena Pharmaceuticals Inc shares in Q2 2021, an estimated $9K.
  • Wealthcare Advisory Partners first reported a position in Arena Pharmaceuticals Inc in Q1 2020 and held it in 2 quarters.
  • Wealthcare Advisory Partners's Arena Pharmaceuticals Inc position peaked at $9K in Q1 2021.
  • 237 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q2 2021.

Based on Wealthcare Advisory Partners's 13F filing for Q2 2021, filed 16 Aug 2021.